115. SURVIVAL ANALYSIS AND REASONS FOR DISCONTINUING OR SWITCHING TUMOUR NECROSIS FACTOR INHIBITORS IN AXIAL SPONDYLOARTHRITIS: FINDINGS FROM A REAL-LIFE UK COHORT | Zendy

AI Assistant Blog Pricing

115. SURVIVAL ANALYSIS AND REASONS FOR DISCONTINUING OR SWITCHING TUMOUR NECROSIS FACTOR INHIBITORS IN AXIAL SPONDYLOARTHRITIS: FINDINGS FROM A REAL-LIFE UK COHORT

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.